EQUITY RESEARCH MEMO

iFIT Prosthetics

Generated 5/10/2026

Executive Summary

Conviction (model self-assessment)70/100

iFIT Prosthetics is a US-based medical device company specializing in immediate-fit, fully adjustable prosthetic sockets for lower limb amputees. Its patented technology enables custom fitting in a single clinical session, eliminating the need for multiple appointments and traditional casting. The patient-adjustable volume management system allows users to accommodate limb fluctuations, enhancing comfort and mobility. By streamlining the fitting process and reducing costs, iFIT aims to improve access to high-quality prosthetics and accelerate rehabilitation for amputees worldwide. The company addresses a significant unmet need in the prosthetic market, where traditional sockets require lengthy fabrication and often lead to poor fit and patient dissatisfaction. iFIT's innovative approach has the potential to disrupt the industry by offering a cheaper, faster, and more comfortable solution. With a strong foothold in the US market and a focus on expanding globally, iFIT is well-positioned to capture a share of the growing prosthetic market. However, the company faces competition from established players and must navigate regulatory and reimbursement challenges. Overall, iFIT's technology could meaningfully improve the quality of life for amputees, making it a compelling investment opportunity.

Upcoming Catalysts (preview)

  • Q4 2026FDA 510(k) clearance for next-generation adjustable socket60% success
  • Q3 2026Strategic distribution partnership with major prosthetic supplier50% success
  • Q2 2026Publication of clinical study showing improved mobility outcomes70% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)